Sartan Drugs Have Been Deemed in Shortage by the FDA

sartan drugs

The US Food and Drug Administration (FDA) is warning that there is a shortage of drugs that is used by millions to treat high blood pressure. The drugs known as Continue Reading

LC-MS/MS Method for Determination of NDMA and NDEA in Valsartan

Valsartan

By: Philip J. Koerner, Ph.D. – Global Industry Manager – Pharmaceutical The Korea Food and Drug Administration (KFDA), in cooperation with SCIEX Korea, has recently published an official LC-MS/MS method using Continue Reading